Corporate
Program Info

French Biotech International Business Programme in Gothenburg & Copenhagen: October 13-16!

Sectors

Lifestyle & Healthcare

Countries

Business France, in partnership with Bpifrance, is once again organizing the Biotech International Business Programme in Sweden and Denmark. This initiative supports French biotechnology companies in expanding into the Nordic markets - renowned for their excellence in life sciences - and aims to strengthen collaborations between France and Scandinavia.

From October 13 to 16, Business France will welcome a delegation of 11 innovative French biotech companies to Gothenburg, Sweden and Copenhagen, Denmark and representatives from bpifrance, France’s public investment bank and the innovation agency!

The delegation will attend the NLSDays partnering event and participate in a tailored program of meetings with Nordic pharmaceutical companies, organized with the support of local partners.

The dynamism of France’s Biotech sector

France’s biotech sector is one of the most dynamic in Europe, with over 2 429 companies in Life Sciences (Biotech Gate 2024) driving innovation in areas like oncology, rare diseases, and digital health. Backed by strong government support and a thriving research ecosystem, the industry is projected to more than double in value by 2030, reaching over $129 billion. (Grand View Research).

French start-ups & SMEs participating in the Programme

We are excited to present a group of 11 French biotech companies that exemplify cutting-edge innovation in oncology, immunotherapy, biosourced drug delivery, and advanced cell modeling. From acoustic wave-based cell manufacturing to AI-driven organoid screening and real human data platforms, they represent a vibrant ecosystem pushing the boundaries of personalized medicine and therapeutic development.

Albupad – The Next Generation of Biosourced Materials for Active Drug Delivery
AlphaOnco – Innovative solid tumor cancer therapy, safe effective and non-invasive
Altevax – A first-in-class immunotherapy against cancer
Antineo – A CRO for preclinical studies in oncology
4D Cell – 2D & 3D models to redefine in vitro standards to select the right molecules
Doxanano – Remotely activated chemotherapy, pushing the limits of conventional chemotherapy
Egle Therapeutics – Modulate regulatory T cells to rebalance immunity for oncology and autoimmune disease
ExAdEx-Innov – Shaping research with real human data
Kolibri – Reimaging cell manufacturing using acoustic waves
Okomera – Automated Organoid Screening: Plug. Generate. Screen, Discover
Texcell – Biosafety services: protecting Tomorrow’s Medicines. Today

Discover more about each company in the detailed catalog.

Meet the companies

You will have several opportunities to meet the companies:

October 13 & 14 – NLSDays partnering: You can book a meeting directly through the PartneringONE Platform with all of the companies!
October 15 – Side event in Gothenburg with key ecosystem players: AstraZeneca, Sahlgrenska University Hospital, Chalmers ventures.
October 16 – pitch session with leading Danish pharmaceutical companies at the Embassy of France in Denmark and B2B meetings with the Danish ecosystem in collaboration with Enterprise Europe Network Denmark

We can also arrange individual meetings with one or several companies if their technology interests you. Please reach out to Soline for the Swedish market (soline.remond@businessfrance.fr) or Annemette for the Danish market (annemette.jensen@businessfrance.fr) to connect with the delegation or for any other questions related to this programme!